⌘K

Login Start Free

Home/Filings/4/0001193125-25-309751

4//SEC Filing

Weill David 4

Accession 0001193125-25-309751

CIK 0001756262other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:30 PM ET

Size

7.8 KB

Accession

0001193125-25-309751

Insider Transaction Report

Form 4

Period: 2025-12-03

TransMedics Group, Inc.TMDX

Director

Transactions

Exercise/Conversion
Common Stock
2025-12-03$14.20/sh+5,000$71,000→ 17,134 total
Sale
Common Stock
2025-12-03$138.64/sh−5,000$693,200→ 12,134 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-12-03−5,000→ 5,000 total
Exercise: $14.20Exp: 2030-06-04→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]The option is fully vested.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1

filerCIK 0001774270

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 4:30 PM ET
Size: 7.8 KB

View on SEC.gov